title: Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab'.
authors.affiliation: Pathology Department, Institut régional du Cancer Montpellier, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France.
authors.forename: F
authors.initials: F
authors.lastname: Bibeau
authors.forename: H
authors.initials: H
authors.lastname: Gil
authors.forename: F
authors.initials: F
authors.lastname: Castan
authors.forename: F
authors.initials: F
authors.lastname: Boissière-Michot
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized